Differential mTOR and ERK pathway utilization by effector CD4 T cells suggests combinatorial drug therapy of arthritis.
about
Multidrug therapy for polycystic kidney disease: a review and perspective.Emerging immunotherapies for rheumatoid arthritis.Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumor microenvironment.An update on the pathophysiology and management of polycystic liver disease.CZ415, a Highly Selective mTOR Inhibitor Showing in Vivo Efficacy in a Collagen Induced Arthritis Model.Targeted immunosuppression: no longer naïve.
P2860
Differential mTOR and ERK pathway utilization by effector CD4 T cells suggests combinatorial drug therapy of arthritis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Differential mTOR and ERK path ...... ial drug therapy of arthritis.
@ast
Differential mTOR and ERK path ...... ial drug therapy of arthritis.
@en
type
label
Differential mTOR and ERK path ...... ial drug therapy of arthritis.
@ast
Differential mTOR and ERK path ...... ial drug therapy of arthritis.
@en
prefLabel
Differential mTOR and ERK path ...... ial drug therapy of arthritis.
@ast
Differential mTOR and ERK path ...... ial drug therapy of arthritis.
@en
P2093
P2860
P1433
P1476
Differential mTOR and ERK path ...... ial drug therapy of arthritis.
@en
P2093
C Garrison Fathman
Emily A Stein
Jack T Lin
Krishna J Kalpathy
Michael T Wong
Paul J Utz
William H Robinson
P2860
P304
P356
10.1016/J.CLIM.2011.09.008
P577
2011-10-01T00:00:00Z